Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Saved in:
| Title: | Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed. |
|---|---|
| Authors: | Imai, Hisao1,2 (AUTHOR) m06701014@gunma-u.ac.jp, Wasamoto, Satoshi3 (AUTHOR), Tsuda, Takeshi4 (AUTHOR), Nagai, Yoshiaki5 (AUTHOR), Kishikawa, Takayuki6 (AUTHOR), Masubuchi, Ken2 (AUTHOR), Osaki, Takashi7 (AUTHOR), Miura, Yosuke8 (AUTHOR), Umeda, Yukihiro9 (AUTHOR), Ono, Akihiro10 (AUTHOR), Minemura, Hiroyuki11 (AUTHOR), Yamada, Yutaka12 (AUTHOR), Nakagawa, Junichi13 (AUTHOR), Kozu, Yuki3 (AUTHOR), Taniguchi, Hirokazu4 (AUTHOR), Ohta, Hiromitsu5 (AUTHOR), Kasai, Takashi6 (AUTHOR), Kaira, Kyoichi1 (AUTHOR), Kagamu, Hiroshi1 (AUTHOR) |
| Source: | Thoracic Cancer. Sep2023, Vol. 14 Issue 25, p2567-2578. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
